Quitting smoking improves multiple cardiovascular and metabolic risk factors
For patients with BMI 30 or 27 with comorbidities, FDA-approved pharmacotherapy may be appropriate alongside lifestyle modification
Compounded semaglutide $1,700 to $5,000 depending on provider
Traditional thinking viewed glucagon as counterproductive for blood sugar control since glucagon signals the liver to release stored glucose, raising blood sugar levels
Consequently, the internal jugular veins dilate and pressure within them increases [43, 50, 51]
We utilize a precision medicine obesity model, combining these powerful pharmaceutical tools with bespoke Peptide Therapy , NAD+ support , and personalized nutrition plans to ensure that patients are losing fat, preserving muscle mass , and fundamentally improving their biological age, not just their physical appearance. This integrative approach, leveraging these powerful agents alongside complementary protocols, is the defining standard of doctor-supervised medical weight loss in Connecticut